Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pitavastatin or bezafibrate intervention, assessment of antiarteriosclerotic effect (PIONEER).

Trial Profile

Pitavastatin or bezafibrate intervention, assessment of antiarteriosclerotic effect (PIONEER).

Completed
Phase of Trial: Phase III

Latest Information Update: 22 May 2014

At a glance

  • Drugs Pitavastatin (Primary) ; Bezafibrate
  • Indications Atherosclerosis; Hyperlipidaemia
  • Focus Therapeutic Use
  • Acronyms PIONEER
  • Most Recent Events

    • 20 Nov 2013 Status changed from active, no longer recruiting to completed.
    • 20 Nov 2013 Results presented at the 86th Annual Scientific Sessions of the American Heart Association.
    • 18 Nov 2013 Primary endpoint 'Intima-media-thickness' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top